Literature DB >> 33210481

[Effects of delivery and storage conditions on concentrations of amino acids and carnitines in neonatal dried blood spots].

Lingwei Hu1, Zhenzhen Hu1, Jianbin Yang1, Yu Zhang2, Yezhen Shi2, Shasha Zhu3, Rulai Yang1, Xinwen Huang1.   

Abstract

OBJECTIVE: To explore effects of different delivery and storage conditions on concentrations of amino acids and carnitines in neonatal dried blood spots (DBS), so as to provide evidence for improving accurate and reliable detection by tandem mass spectrometry.
METHODS: A total of 1 254 616 newborn DBS samples in Newborn Screening Center of Zhejiang Province were delivered and stored at room temperature (group A, n=338 467), delivered by cold-chain logistics system and stored at low temperature (group B, n=480 021), or delivered by cold-chain logistics system and stored at low temperature and low humidity (group C, n= 436 128), respectively. The concentrations of amino acids and carnitines in DBS were detected by tandem mass spectrometry. Data analysis was performed by SPSS 24.0 to explore the influence of temperature and humidity on the concentrations of amino acids and carnitines.
RESULTS: The concentrations of amino acids and carnitines in the three groups were skewed, and the differences in amino acid and carnitine concentrations among groups were statistically significant (all P<0.01). The median concentration of tyrosine was lower in group A than those in group B and group C by 18%and 16%respectively, while there was no significant difference between the last two groups. The median concentrations of methionine were lower in group A and group B than that in group C by 15%and 11%, respectively. The median concentrations of arginine were lower in group A and group B than that in group C by 12%and 25%, respectively. The median concentration of free carnitine (C0) was higher in group A than that in group C by 12%, while there was no significant difference between group A and group B. The median concentrations of acetylcarnitine (C2), propionyl carnitine (C3), C3DC+C4OH, C5DC+C6OH and hexadecanoyl carnitine (C16) were lower in group A than those in group B and group C by 21%-64%. The concentrations of other amino acids and acylcarnitines differed little among three groups. The monthly median coefficients of variation of other amino acids and carnitines in group A were higher than those in group B and group C except for citrulline, C4DC+C5OH and isovalerylcarnitine (C5).
CONCLUSIONS: Cold-chain logistics system and storage in low temperature and low humidity can effectively reduce degradation of some amino acids and carnitines in DBS, improve the accuracy and reliability of detection, and thus ensures the quality of screening for neonatal metabolic diseases.

Entities:  

Keywords:  Amino acids; Carnitine; Cold-chain transportation; Dried blood spot testing; Genetic and metabolic diseases screening; Humidity; Storage; Temperature

Mesh:

Substances:

Year:  2020        PMID: 33210481      PMCID: PMC8800740          DOI: 10.3785/j.issn.1008-9292.2020.10.03

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  14 in total

1.  Validation of accuracy-based amino acid reference materials in dried-blood spots by tandem mass spectrometry for newborn screening assays.

Authors:  D H Chace; B W Adam; S J Smith; J R Alexander; S L Hillman; W H Hannon
Journal:  Clin Chem       Date:  1999-08       Impact factor: 8.327

2.  The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States.

Authors:  B W Adam; E M Hall; M Sternberg; T H Lim; S R Flores; S O'Brien; D Simms; L X Li; V R De Jesus; W H Hannon
Journal:  Clin Biochem       Date:  2011-09-21       Impact factor: 3.281

3.  Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM).

Authors:  Joanne V Mei; LiXia Li; Sonja A Rasmussen; Sarah Collier; Jaime L Frias; Margaret A Honein; Gary M Shaw; Fred Lorey; Robert Meyer; Shu Chaing; Mark A Canfield; Jeffrey Jones; W Harry Hannon
Journal:  Clin Chim Acta       Date:  2010-11-27       Impact factor: 3.786

4.  Long-term stability of amino acids and acylcarnitines in dried blood spots.

Authors:  Kristina Anna Strnadová; Margareta Holub; Adolf Mühl; Georg Heinze; Rene Ratschmann; Hermann Mascher; Sylvia Stöckler-Ipsiroglu; Franz Waldhauser; Felix Votava; Jan Lebl; Olaf A Bodamer
Journal:  Clin Chem       Date:  2007-02-01       Impact factor: 8.327

5.  Stability of metabolites in dried blood spots stored at different temperatures over a 2-year period.

Authors:  Philippa Prentice; Charles Turner; Max Cy Wong; R Neil Dalton
Journal:  Bioanalysis       Date:  2013-06       Impact factor: 2.681

6.  Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: statement of the Council of Regional Networks for Genetic Services.

Authors:  B L Therrell; W H Hannon; K A Pass; F Lorey; C Brokopp; J Eckman; M Glass; R Heidenreich; S Kinney; S Kling; G Landenburger; F J Meaney; E R McCabe; S Panny; M Schwartz; E Shapira
Journal:  Biochem Mol Med       Date:  1996-04

7.  Short-Term Stabilities of 21 Amino Acids in Dried Blood Spots.

Authors:  Jun Han; Rehan Higgins; Mark D Lim; Karen Lin; Juncong Yang; Christoph H Borchers
Journal:  Clin Chem       Date:  2017-11-02       Impact factor: 8.327

8.  Stability of amino acids and galactose in the newborn screening filter paper blood specimen.

Authors:  H L Levy; J R Simmons; R A MacCready
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

9.  Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.

Authors:  Ralph Fingerhut; Regina Ensenauer; Wulf Röschinger; Ralf Arnecke; Bernhard Olgemöller; Adelbert A Roscher
Journal:  Anal Chem       Date:  2009-05-01       Impact factor: 6.986

Review 10.  Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges.

Authors:  Mark D Lim
Journal:  Am J Trop Med Hyg       Date:  2018-06-28       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.